Technical Resources International, Inc.

What Technical Resources International, Inc. does

Technical Resources International, Inc. (TRI) is a privately held, minority-woman-owned Contract Research Organization (CRO) founded in 1979 and headquartered in Bethesda, Maryland. The company provides integrated clinical research, clinical communications, and information technology services to federal agencies (notably HHS, NIH, and the Department of Commerce), pharmaceutical companies, biotech firms, medical device manufacturers, and non-profit organizations. Its Clinical Solutions division delivers full-service Phase I-IV trial support across biostatistics, data management, regulatory affairs, medical writing, safety/pharmacovigilance, and clinical operations; the Clinical Communications division handles marketing, eLearning, multimedia production, and event management; and the Technology division provides systems integration, validation, web application development, and technology adoption support for clinical research workflows.

TRI's underlying technology stack is built on FDA/GCP- and 21 CFR Part 11-compliant platforms, with proprietary assets including the TRI Analytics Platform (SAS-based BI with predictive accrual modeling), a Clinical Data Architecture integration engine, an AS2 Gateway for secure global regulatory submissions, and decentralized clinical trial tooling (eSource, ePRO, eCOA, wearables). Quality and security posture is anchored by ISO 9001 and ISO 27001:2013 certifications, FISMA and Section 508 compliance for federal work, and GDPR/CCPA adherence for international data. The firm advertises a 99%+ HHS/NIH contract rating and supports clinical operations across 80+ countries, with regional subsidiaries TRI CRO S.A.C. (Peru) and TRI CRO S.A.S. (Colombia), plus a Dublin, Ireland office.

Revenue is generated primarily through professional-services contracts: enterprise engagements with pharma, biotech, and medical device clients via direct sales; federal work through the GSA Professional Services Schedule contract GS-00F-274CA covering advertising, public relations, market research, video production, conference planning, and marketing consulting SINs; and outreach, event management, and eLearning revenue streams supporting clinical programs. Leadership consists of CEO Nora Lee, President Vanessa Brennan, CFO Margarite Lin (CPA), and COO Daniel Molina (PharmD, MBA). No public financials, funding history, or acquisition activity is disclosed.

Name

Technical Resources International, Inc.

Legal name

Technical Resources International, Inc.

Website

https://tech-res.com

Company type

Private

Founded year

1979

Operating status

Operating

Headcount range

101–250 employees

Short description

Technical Resources International, Inc. (TRI) is a privately held, woman- and minority-owned CRO founded in 1979 that provides full-service Phase I-IV clinical research, biostatistics, regulatory, safety, communications, and clinical IT services to U.S. federal agencies, pharmaceutical, biotech, and medical device clients.

Ownership category

akta.pro rank

Product category

Contract Research Organization Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

Keywords

• Clinical research services
• Contract research organization
• Biostatistics services
• Regulatory affairs consulting
• Pharmacovigilance services

Headquarters

HQ city

Bethesda

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Full-Service Clinical Research Solutions: TRI provides full-spectrum Clinical Research Solutions supporting Phase I-IV observational and interventional trials. Revenue is generated through comprehensive CRO services including clinical operations, data management, biostatistics, regulatory, and safety services. Offers both full-service and Functional Service Provider (FSP) models.
2. Technology Solutions: Technology services including systems integration, validation, web application development, and technology adoption support. These specialized IT services for clinical trials generate revenue through project-based engagements and ongoing support.
3. Clinical Communications Services: End-to-end clinical communications including marketing and outreach, multimedia design and production, training and eLearning, and event planning and management. Services range from under 10 to over 5,000 attendees.
4. GSA Federal Contract Vehicles: TRI participates in GSA contract GS-00F-274CA (Professional Services Schedule) providing services under various SINs including advertising, public relations, market research, video production, conference planning, and marketing consulting services to federal clients.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Technical Resources International, Inc. (TRI) is a Contract Research Organization (CRO) providing integrated clinical research services spanning Phase I-IV trials, biostatistics, data management, regulatory affairs, medical writing, and safety/pharmacovigilance for drugs, biologics, and medical devices. The company complements these with clinical communications (marketing, eLearning, multimedia, event planning) and specialized clinical research IT (systems integration, validation, web application development) for government, pharmaceutical, biotech, medical device, and non-profit clients globally.

Product overview

TRI is an award-winning, minority-woman-owned Contract Research Organization (CRO) providing integrated clinical research services through three interconnected divisions: Clinical Solutions, Clinical Communications, and Technology. The Clinical Solutions division offers a comprehensive portfolio spanning the full drug development lifecycle—from Phase I first-in-human studies through Phase IV post-marketing surveillance—covering biostatistics, data management, regulatory affairs, medical writing, safety/pharmacovigilance, and clinical operations. The Clinical Communications division delivers integrated marketing, training/eLearning, multimedia design, and event planning services. The Technology division provides systems integration, validation, adoption support, and web application development. These three divisions work together as an integrated ecosystem: Technology powers the data infrastructure for Clinical Solutions, while Clinical Communications supports participant recruitment and retention for clinical trials managed by Clinical Solutions.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Solutions

Quantifiable outcome

• 99%+ HHS/NIH Contract Rating
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature8 records

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Medpace Holdings: Mid-to-large full-service CRO with strong Phase I-IV clinical operations, biostatistics, data management, and regulatory services. Comparable in operating model and therapeutic breadth, though larger in scale and publicly traded.
• Worldwide Clinical Trials: Mid-size, privately held CRO offering full-service clinical development with therapeutic specialization similar to TRI. Comparable size, ownership profile, and full-service model make it a strong direct comp.
• Premier Research: Mid-size CRO with strong presence in rare disease, oncology, and pediatric trials — overlapping therapeutic specialties and mid-market positioning with TRI. Comparable service breadth and federal/biotech client mix.
• Veristat: Smaller, therapeutically-focused CRO providing clinical operations, biostatistics, and regulatory services. Comparable service model for Phase II-IV programs targeting small-to-mid biotech sponsors.
• Rho: US-based, privately held mid-size CRO with strong federal and biotech client mix, focused on clinical operations, biostatistics, data management, and regulatory. Closest peer by size, ownership structure, and client profile.
• EMMES: Privately held CRO with deep federal government and NIH research portfolio, providing full-service clinical trial support. Closely comparable in federal contracting focus and therapeutic specialization (rare disease, public health).

Broad incumbents

• PPD (Thermo Fisher Scientific): One of the world's largest CROs offering comprehensive clinical development and laboratory services across all phases. Overlaps substantially with TRI's services but operates at global mega-scale following acquisition by Thermo Fisher.
• IQVIA: Largest global CRO with comprehensive Phase I-IV services, technology platforms, and real-world data capabilities. Significant overlap with TRI but with vastly greater scale, global footprint, and technology infrastructure.
• ICON plc: Top-tier global CRO formed via PRA Health Sciences merger, offering full-service clinical development with strong data/biometrics capabilities. Direct competitor for enterprise pharma trials but at much larger scale.
• Syneos Health: Global full-service CRO and contract commercial organization offering clinical development services overlapping with TRI's clinical operations and biostatistics offerings. Significantly larger scale with broader commercial capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/tricroplus
• LinkedInlinkedin.com/company/technical-resources-international-inc

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Technical Resources International, Inc.